M. Alexandra Rohall
Sr. Manager, Medical Writing
Ms. Rohall has 23 years of experience in clinical drug development, primarily in the preparation of regulatory submission documents and clinical trial reports. At PROMETRIKA, Ms. Rohall leads the medical writing group in the design of regulatory-compliant reports and summary documents. Her experience encompasses the planning and preparation of New Drug Applications (NDAs) in both the traditional and CTD formats.
Prior to joining PROMETRIKA, Ms. Rohall served as the Manager of Operations for North American Medical Writing Services at PAREXEL International. In that role, she managed the budgeting, resourcing, and planning of medical writing activities within the department. She was responsible for corporate proposal and contract development with regard to medical writing services.
Early in her career, Ms. Rohall served as a clinical research associate with Ortho Pharmaceuticals (now Johnson & Johnson Pharmaceutical Research and Development) and began her writing activities with Besselaar (now Covance).
Ms. Rohall received her Bachelor of Arts in Biology from the University of Rochester (NY) in 1982, and her certification in medical technology (MT ASCP) at St. Mary’s Hospital, Rochester, NY, in 1983.Principal Staff
Miganush Stepanians, PhD
President and CEO
Faith Haines Kolb
Senior Director,
Clinical Operations
and
Data Management
Nicole LaVallee, PhD
Director, Biostatistics
Heidy Kwan Russell, PhD
Director, Biostatistics
M. Alexandra Rohall
Sr. Manager, Medical Writing
Judith Harris
Head of Quality Systems
and Project Management
Kathleen Murphy, CCRA
Associate Director,
Clinical Operations
Colleen Cox, CCDM
Manager, Data Management
Christopher Gallant, BS
Manager, Client Relations
Rob A. Ferragamo,
MCP, CCA
Director, Information
Technology and
Infrastructure Services

